Skip to content

Combined Laser and Sclerotherapy for Venous Malformations Trial

Semiconductor Laser Combined with Foam Sclerotherapy Versus Foam Sclerotherapy Alone for Complex Trunk Venous Malformations: A Prospective, Open-Label, Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129592
Enrollment
Unknown
Registered
2026-08-06
Start date
2026-08-06
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Malformation (VM)

Interventions

Intervention group:Semiconductor laser combined with foam sclerotherapy
Control group:foam sclerotherapy

Sponsors

Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Age =18 and =70 years (inclusive), regardless of gender. 2.Diagnosis of complex trunk/extremity venous malformations (VMs) with clinical indications for intervention: maximum lesion diameter > 5 cm, with or without pain or functional impairment (e.g., limited joint mobility). 3.Lesions located in the upper or lower extremities (including the buttock and scapular regions). 4.Provision of written informed consent and willingness to comply with scheduled follow-up visits. 5.Anticipated survival > 24 months.

Exclusion criteria

Exclusion criteria: 1.High-flow VMs (AVF confirmed by DSA/US); 2.High-risk anatomy: Infiltrative lesions encasing nerves (>180°) or major arteries (uncontrollable thermal risk); 3.Superficial depth: Lesions 1.5, or ongoing anticoagulation; 5.Severe organ dysfunction: CKD =4 or NYHA =III; 6.Pregnancy, lactation, or allergy to sclerosants (lauromacrogol/bleomycin);

Design outcomes

Primary

MeasureTime frame
Clinical Efficacy Rate;

Secondary

MeasureTime frame
Lesion volume reduction rate and recurrence rate;

Countries

China

Contacts

Public ContactRuihua Wang

Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine

112814732@qq.com+86 21 2327 1699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026